H.B. Fuller (FUL) Hisse Özeti
H.B. Fuller Company, iştirakleriyle birlikte yapıştırıcılar, sızdırmazlık malzemeleri, kaplamalar, polimerler, bantlar, kapsülleyiciler, katkı maddeleri ve diğer özel kimyasal ürünleri formüle etmekte, üretmekte ve pazarlamaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 2/6 |
| Gelecekteki Büyüme | 1/6 |
| Geçmiş Performans | 4/6 |
| Finansal Sağlık | 3/6 |
| Temettüler | 5/6 |
FUL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
H.B. Fuller Company Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$61.95 |
| 52 Haftanın En Yüksek Seviyesi | US$68.63 |
| 52 Haftanın En Düşük Seviyesi | US$48.71 |
| Beta | 0.96 |
| 1 Aylık Değişim | 2.30% |
| 3 Aylık Değişim | 4.70% |
| 1 Yıllık Değişim | -0.064% |
| 3 Yıllık Değişim | -10.53% |
| 5 Yıllık Değişim | -4.07% |
| Halka arzdan bu yana değişim | 2,452.45% |
Son Haberler & Güncellemeler
Seeking Alpha • 3h
H.B. Fuller: Overreaction, Or Proof Of Slowdown
Summary H.B. Fuller is rated a "buy" with a conservative $80/share price target, reflecting improved fundamentals and recent M&A. FUL’s recent results validate earnings recovery: near-6% revenue growth, ~20% AEPS improvement, double-digit EBITDA gains, and record operating cash flow. The AMS acquisition is expected to drive margin expansion, higher-quality revenue, and meaningful revenue and cost synergies, supporting long-term profitability. FUL now justifies a 15x P/E target based on sustained growth and improved margins, making the risk/reward attractive into 2026–2027. Read the full article on Seeking AlphaAnaliz Makalesi • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...Recent updates
Seeking Alpha • 3h
H.B. Fuller: Overreaction, Or Proof Of Slowdown
Summary H.B. Fuller is rated a "buy" with a conservative $80/share price target, reflecting improved fundamentals and recent M&A. FUL’s recent results validate earnings recovery: near-6% revenue growth, ~20% AEPS improvement, double-digit EBITDA gains, and record operating cash flow. The AMS acquisition is expected to drive margin expansion, higher-quality revenue, and meaningful revenue and cost synergies, supporting long-term profitability. FUL now justifies a 15x P/E target based on sustained growth and improved margins, making the risk/reward attractive into 2026–2027. Read the full article on Seeking AlphaAnaliz Makalesi • Jun 18
H.B. Fuller (FUL) Stock Could Be 8% Undervalued After Its 2025 Sustainability Report
H.B. Fuller (FUL) is in focus after publishing its 2025 Sustainability Report, which sets out 2030 goals on greenhouse gas emissions, water use, and waste intensity, and links these efforts to operations and customer demand. See our latest analysis for H.B. Fuller. Recent trading suggests momentum in H.B. Fuller stock has been picking up, with a 30 day share price return of 11.27% and a 90 day share price return of 28.74%. The 1 year total shareholder return of 21.62% gives investors context...
Anlatı Güncellemesi • Jun 16
FUL: Medical Deal Uncertainty And Activist Pressure Will Shape Future Outlook
Analysts have made a small, valuation-driven adjustment to their view on H.B. Fuller, with the blended price target holding close to prior levels as updated models reflect a slightly lower discount rate, largely stable fair value at about $70, and balanced input from recent upgrades and price target revisions across the Street. Analyst Commentary Recent commentary on H.B. Fuller centers on how potential corporate actions and updated models could influence the stock’s risk and reward profile, with JPMorgan’s upgrade and various price target changes framing a mixed but valuation conscious view.Anlatı Güncellemesi • Jun 02
FUL: Proposed Medical Solutions Deal Will Shape Long Term Outlook
Analysts kept their fair value estimate for H.B. Fuller steady at $70.43 while adjusting assumptions such as the discount rate and long-term growth. This reflected mixed recent price target moves as firms reassessed the stock around potential corporate actions and valuation.Anlatı Güncellemesi • Apr 26
FUL: Raised Guidance And P/E Assumptions Will Support Stronger Long Term Outlook
Analysts have adjusted their outlook on H.B. Fuller, with offsetting moves such as a $3 increase in the price target at Citi and a $3 reduction at UBS. These changes are framed around updated views on valuation inputs such as the discount rate and the assumed future P/E multiple.Anlatı Güncellemesi • Apr 12
FUL: Long Term Assumptions Will Support Balanced Outlook Despite Mixed Guidance
The analyst price target for H.B. Fuller edges slightly lower to about $70.43 from roughly $70.71, as analysts balance recent target increases from several firms with more cautious revisions tied to adjusted growth, margin, and P/E assumptions. Analyst Commentary Recent Street research on H.B. Fuller presents a mixed picture, with several firms adjusting price targets both higher and lower over the past few months.Anlatı Güncellemesi • Mar 29
FUL: Higher Long Term Assumptions Will Support Upside Despite Mixed Guidance
Analysts trimmed the average H.B. Fuller price target by about $1 to $70.71, reflecting a mix of recent upward and downward revisions as they reassessed assumptions on growth, profitability, and valuation multiples. Analyst Commentary Recent research on H.B. Fuller features a mix of higher and lower price targets.Anlatı Güncellemesi • Mar 14
FUL: Higher P/E Assumptions Will Support Upside Despite Muted Revenue Outlook
Analysts have lifted their consolidated price target on H.B. Fuller by several dollars, with recent $2 to $6 upward revisions tied to their updated views on the company’s earnings power and P/E assumptions. Analyst Commentary Bullish analysts raising their targets by $2 to $6 are largely reacting to updated assumptions on H.B. Fuller’s earnings power and the P/E they are willing to apply to those earnings.Anlatı Güncellemesi • Feb 28
FUL: Free Cash Flow Support Will Offset Modest Outlook And Future P/E Assumptions
H.B. Fuller’s analyst price target has been lifted by several firms, with recent increases of $2 to $6 reflecting analysts’ updated views on its earnings profile and modest adjustments to assumptions such as discount rate, long-term revenue growth, profit margin, and future P/E. Analyst Commentary Recent Street research points to a cluster of higher price targets for H.B. Fuller, with adjustments in the range of $2 to $6.Anlatı Güncellemesi • Feb 14
FUL: Free Cash Flow Support Will Balance Organic Headwinds And Future P/E Expectations
The Street has nudged its view on H.B. Fuller higher, with analysts lifting price targets by $2 to $6 as they point to a mix of free cash flow support and valuation considerations, even as they flag near term organic growth headwinds. Analyst Commentary Recent Street research clusters around a common theme for H.B. Fuller, with price target increases framed against ongoing pressure on near term organic growth.Anlatı Güncellemesi • Jan 31
FUL: Free Cash Flow Support Will Underpin Higher Future P/E Expectations
Analysts have lifted their price targets on H.B. Fuller by between $2 and $6, citing updated views on valuation, free cash flow support, and a slightly higher assumed future P/E multiple in their models. Analyst Commentary Recent research updates show a cluster of higher price targets for H.B. Fuller, with several firms revisiting their models to reflect revised valuation assumptions, free cash flow support, and modestly higher assumed future P/E multiples.Anlatı Güncellemesi • Jan 17
FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power
Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.Analiz Makalesi • Jan 08
Investors Will Want H.B. Fuller's (NYSE:FUL) Growth In ROCE To Persist
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analiz Makalesi • Nov 14
We Think H.B. Fuller (NYSE:FUL) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analiz Makalesi • Oct 03
There May Be Reason For Hope In H.B. Fuller's (NYSE:FUL) Disappointing Earnings
Soft earnings didn't appear to concern H.B. Fuller Company's ( NYSE:FUL ) shareholders over the last week. Our analysis...Analiz Makalesi • Sep 30
H.B. Fuller Company Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Shareholders might have noticed that H.B. Fuller Company ( NYSE:FUL ) filed its quarterly result this time last week...Anlatı Güncellemesi • Sep 28
ND Industries Integration And HHC Pricing Will Secure Stability
Analysts have raised H.B. Fuller's price target to $68.83, citing confidence in continued EBITDA growth, margin expansion, and operational execution despite a weak growth environment. Analyst Commentary Bullish analysts highlight solid year-over-year EBITDA growth expected in fiscal 2025, despite a sluggish growth environment.Analiz Makalesi • Aug 30
Estimating The Intrinsic Value Of H.B. Fuller Company (NYSE:FUL)
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$53.78 With US$61.05...Analiz Makalesi • Aug 14
H.B. Fuller Company's (NYSE:FUL) P/E Is On The Mark
H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...Analiz Makalesi • Jul 30
Is Now The Time To Look At Buying H.B. Fuller Company (NYSE:FUL)?
While H.B. Fuller Company ( NYSE:FUL ) might not have the largest market cap around , it saw a double-digit share price...Analiz Makalesi • Jul 15
There's Been No Shortage Of Growth Recently For H.B. Fuller's (NYSE:FUL) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Analiz Makalesi • May 22
Is H.B. Fuller Company (NYSE:FUL) Worth US$54.7 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, H.B. Fuller fair value estimate is US$41.64 H.B. Fuller is...Analiz Makalesi • May 07
H.B. Fuller (NYSE:FUL) Takes On Some Risk With Its Use Of Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analiz Makalesi • Apr 19
H.B. Fuller (NYSE:FUL) Will Pay A Larger Dividend Than Last Year At $0.235
The board of H.B. Fuller Company ( NYSE:FUL ) has announced that it will be increasing its dividend by 5.6% on the 13th...Analiz Makalesi • Apr 10
Here's What To Make Of H.B. Fuller's (NYSE:FUL) Decelerating Rates Of Return
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...Analiz Makalesi • Mar 13
Shareholders Should Be Pleased With H.B. Fuller Company's (NYSE:FUL) Price
With a price-to-earnings (or "P/E") ratio of 22.4x H.B. Fuller Company ( NYSE:FUL ) may be sending bearish signals at...Analiz Makalesi • Feb 21
What Is H.B. Fuller Company's (NYSE:FUL) Share Price Doing?
H.B. Fuller Company ( NYSE:FUL ), is not the largest company out there, but it saw significant share price movement...Analiz Makalesi • Jan 23
We Think You Can Look Beyond H.B. Fuller's (NYSE:FUL) Lackluster Earnings
Shareholders appeared unconcerned with H.B. Fuller Company's ( NYSE:FUL ) lackluster earnings report last week. We...Seeking Alpha • Jan 17
Evaluation Of H.B. Fuller After A 30% Decline
Summary H.B. Fuller missed analysts' estimates for the second consecutive quarter, leading to a 3% stock decline and hitting a nearly 3-year low. Despite recent stagnation, H.B. Fuller expects to realize price hikes in 2025, with projected earnings per share growth of 5% and potential for significant future gains. The stock's sharp 30% decline is attributed to its initially high valuation; it now trades at a more reasonable 15.0x forward P/E ratio. Given its cyclical nature, H.B. Fuller offers substantial upside potential but is not a long-term hold; investors should reassess at $79 target. Read the full article on Seeking AlphaAnaliz Makalesi • Dec 21
Does H.B. Fuller (NYSE:FUL) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Hissedar Getirileri
| FUL | US Chemicals | US Pazar | |
|---|---|---|---|
| 7D | -4.5% | 0.7% | -2.7% |
| 1Y | -0.06% | 7.4% | 18.6% |
Getiri vs. Endüstri: FUL geçen yıl % 7.4 oranında getiri sağlayan US Chemicals sektörünün gerisinde kaldı.
Getiri vs Piyasa: FUL geçen yıl % 18.6 oranında getiri sağlayan US Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| FUL volatility | |
|---|---|
| FUL Average Weekly Movement | 5.5% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: FUL son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: FUL 'nin haftalık oynaklığı ( 6% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1887 | 7,100 | Celeste Mastin | www.hbfuller.com |
H.B. Fuller Company, iştirakleri ile birlikte yapıştırıcılar, sızdırmazlık ürünleri, kaplamalar, polimerler, bantlar, kapsülleyiciler, katkı maddeleri ve diğer özel kimyasal ürünleri formüle eder, üretir ve pazarlar. Şirket üç segmentte faaliyet göstermektedir: Hijyen, Sağlık ve Tüketim Yapıştırıcıları; Mühendislik Yapıştırıcıları; ve Yapı Yapıştırıcı Çözümleri. Hijyen, Sağlık ve Tüketim Yapıştırıcıları segmenti, ambalajlama, dönüştürme, nonwoven ve hijyen ile medikal ve güzellik dahil olmak üzere çeşitli pazarlardaki uygulamalar için termoplastik, termoset, reaktif, su bazlı ve solvent bazlı ürünler gibi özel endüstriyel yapıştırıcılar üretir ve tedarik eder.
H.B. Fuller Company Temel Bilgiler Özeti
| FUL temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$3.47b |
| Kazançlar(TTM) | US$185.74m |
| Gelir(TTM) | US$3.51b |
17.9x
F/K Oranı0.9x
P/S OranıFUL aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| FUL gelir tablosu (TTM) | |
|---|---|
| Gelir | US$3.51b |
| Gelir Maliyeti | US$2.38b |
| Brüt Kâr | US$1.13b |
| Diğer Giderler | US$945.59m |
| Kazançlar | US$185.74m |
Son Raporlanan Kazançlar
May 30, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | 3.45 |
| Brüt Marj | 32.25% |
| Net Kâr Marjı | 5.29% |
| Borç/Özkaynak Oranı | 99.5% |
FUL uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünTemettüler
1.5%
Mevcut Temettü Verimi28%
Ödeme OranıŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/06/25 16:02 |
| Gün Sonu Hisse Fiyatı | 2026/06/25 00:00 |
| Kazançlar | 2026/05/30 |
| Yıllık Kazançlar | 2025/11/29 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları GitHub sayfamızda mevcuttur; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
H.B. Fuller Company 12 Bu analistlerden 7, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Ghansham Panjabi | Baird |
| Paretosh Misra | Berenberg |
| Patrick Cunningham | Citigroup Inc |